In this episode of the APAPP podcast, Corinne Young and Amanda Michaud discuss the current landscape of biologic therapies for asthma, focusing on the six available biologics, their mechanisms, and how to choose the right one for patients. They delve into the importance of biomarkers, particularly eosinophil counts, in guiding treatment decisions. The conversation also covers the differences in treatment approaches for pediatric and adult patients, the role of comorbidities, and the future of biologic therapies. Additionally, they explore the relationship between immunotherapy and biologic therapy, emphasizing the need for careful patient management and collaboration between specialists.

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA
Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
Follow us on:

• Instagram @pulmapps
• Twitter@pulmapp
• Facebook @association of pulmonary advance practice providers.

In this episode, COPD Committee Chair, Tyler Kuhk, and Brian Bizik discuss the significant updates in the GOLD 2025 recommendations for COPD management. They explore the history and purpose of the GOLD guidelines, key changes in treatment recommendations, the introduction of new therapeutics, and the implications for patient care. The conversation also addresses the challenges of implementing these changes in clinical practice, particularly regarding costs and patient access to new medications. Overall, the episode highlights the evolving landscape of COPD management and the importance of staying informed about guideline updates.

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA
Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
Follow us on:

• Instagram @pulmapps
• Twitter@pulmapp
• Facebook @association of pulmonary advance practice providers.

In this podcast episode, Rebecca Priebe, Chelsea Koskovich, and Amy Moore discuss Zephyr valves as a treatment option for patients with severe emphysema. They provide insights into the mechanism of the valve, patient selection criteria, the workup process, and the benefits observed in real-world patient outcomes. The conversation emphasizes the importance of early referral for valve procedures, post-procedure care, and managing patient expectations regarding treatment outcomes. The speakers also highlight the role of APPs in educating patients about the procedure and its potential benefits

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA
Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
Follow us on:

• Instagram @pulmapps
• X @pulmapp
• Facebook @association of pulmonary advance practice providers.

In this special episode of the APAPP podcast: Critical Care Edition, our Critical Care Committee Chair, Rhea Votipka, interviews Sue Stembeck about the role of Advanced Practice Providers (APPs) in research. Specifically, they focused on the PREOXI trial published in the New England Journal of Medicine in which Sue was a Principal Investigator. The conversation explores how APPs can engage in research, the responsibilities involved, and the personal and professional rewards that come from participating in research initiatives. The podcast aims to inspire more APPs to get involved in research and highlights the importance of APPs in translating research into practice.

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA
Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
Follow us on:

• Instagram @pulmapps
• Twitter@pulmapp
• Facebook @association of pulmonary advance practice providers.

In this podcast episode, Corinne Young interviews Brian Bizik, a Physician Associate with expertise in respiratory and allergy care. They discuss the topic of asthma-COPD overlap, exploring the definitions and controversies surrounding this condition. They emphasize that asthma and COPD are separate entities that can coexist in one patient, but asthma-COPD overlap is not its own distinct disease. The conversation highlights the importance of identifying and treating the predominant symptoms and inflammatory factors in each patient. They also discuss the different phenotypes and presentations of asthma-COPD overlap and provide insights into treatment options.

Don't forget to claim your CME for listening to this podcast ⁠https://www.pulmapp.com/podcast-episodes/⁠

In this episode, Corinne Young interviews Ray Goodwin, a board-certified family nurse practitioner, about sarcoidosis. They discuss the characteristics of sarcoidosis, including its inflammatory nature and the formation of granulomas in various organs. They also explore the different presentations of sarcoidosis, such as pulmonary, cardiac, and neurosarcoidosis. The conversation covers the diagnostic process as well as imaging review.

Claim your 0.5 CME credits for listening to this episode here: ⁠https://forms.gle/42yHmF8UpemVhdDJA⁠

Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.comFollow us on:

• Instagram @pulmapps
• Twitter@pulmapp
• Facebook @association of pulmonary advance practice providers.

In this episode, we interview Erin Klein Carlson, a respiratory therapist, about the basics of pulmonary function testing. We discuss the reasons for ordering a pulmonary function test, the types of patients that may not be suitable for testing, and the different types of lung function tests available. We also explore the interpretation of flow loops and the importance of z-scores, race and how to approach transgender patients and the challenges of interpreting lung function in this population.

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA
Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
Follow us on:

• Instagram @pulmapps
• Twitter @pulmapp
• Facebook @association of pulmonary advance practice providers.

Dr. Melissa Wilson discusses new treatments in the field of pulmonary hypertension in 2024, focusing on Sotatercept and combination therapy with Opsynvi. Dr. Wilson emphasizes the importance of patient selection and individualized treatment plans. She also discusses the initiation and monitoring of these therapies, as well as potential side effects and patient adherence.

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA.
Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
Follow us on:

• Instagram @pulmapps
• Twitter @pulmapp
• Facebook @association of pulmonary advance practice providers.